1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Pancreatic Surgical Procedure: new trials by email Literature Review of Pancreatic Surgical Procedure trials Research Report on Pancreatic Surgical Procedure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer Biopsy, Biospecimen Collection, Cisplatin - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma | Phase 2 | Recruiting | Georgetown University | 36 | 2024-08-06 | 2026-09-30 |
| Perioperative Therapy for Resectable Pancreatic Cancer gemcitabine hydrochloride, docetaxel, capecitabine - Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer | Phase 2 | Completed | University of Washington | 35 | 2008-01-01 | 2017-07-13 |
Georgetown University (1) · University of Washington (1)
United States (2)
Andrew Coveler (1) · Mihir M. Shah, MD, MS, FACS, FSSO (1)
P30CA015704 (1)